|
May8(Reuters)-EyegatePharmaceuticalsInc(EYEG.O): *EyegatePharmaceuticalsreportsfirstquarter2017financialresultsandprovidesbusinessupdate *Q1revenue$190,000 *EyegatePharmaceuticalsInc-cashandcashequivalentsasofMarch31,2017totaled$5.4million,comparedwith$3.6millionasofDecember31,2016 *EyegatePharmaceuticalsInc-netlossforthreemonthsendedMarch31,2017was$2.9million,comparedwith$2.4millioninQ1of2016 SourcetextforEikon:Furthercompanycoverage:(EYEG.O) |
|
|
